Search

Your search keyword '"Hawkins, Trevor"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Hawkins, Trevor" Remove constraint Author: "Hawkins, Trevor"
285 results on '"Hawkins, Trevor"'

Search Results

1. The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias.

2. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

3. Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

5. The Cerebellar Cognitive Affective / Schmahmann Syndrome Scale in Spinocerebellar Ataxias

7. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

9. The Draft Genome of Ciona intestinalis: Insights into Chordate and Vertebrate Origins

10. Whole-Genome Comparative Analysis of Three Phytopathogenic Xylella fastidiosa Strains

11. Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes

13. The sequence and analysis of duplication rich human chromosome 16

14. The complete sequence of human chromosome 5

15. Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34

16. Whole genome amplification - Review of applications and advances

17. Magnetic bead purification of labeled DNA fragments for high-throughput capillary electrophoresis sequencing

18. Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial

22. Medico-Legal Employability Assessment: Myths, Mistakes and Misconceptions

23. Discovering lactic acid bacteria by genomics

26. Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

29. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

30. An STS-Based Map of the Human Genome

32. Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson Disease: Interim Report on Tolerability (1592)

33. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021)

34. Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients

35. Appearance-related side effects of HIV-1 treatment

36. The DNA sequence and biology of human chromosome 19

37. Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens

38. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates

39. The DNA sequence and comparative analysis of human chromosome 5

41. Epigenetic abnormalities associated with a chromosome 18(q21-q22)inversion and a Gilles de la Tourette syndrome phenotype

42. Initial sequencing and analysis of the human genome

43. A physical map of the human genome

46. Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

47. Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

48. The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Catalog

Books, media, physical & digital resources